ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Tumor Recurrence in Kidney Transplant Recipients with a History of Pretransplant Malignancy

    F. Becker,1 K. Schütte Nütgen,2 S. Reuter,2 L. Kebschull,1 T. Vowinkel,1 N. Senninger,1 D. Palmes,1 T. Vogel,1 R. Bahde.1

    1Department for General and Visceral Surgery, University Hospital Münster, Münster, Germany; 2Department of Internal Medicine D, University Hospital Münster, Münster, Germany.

    Introduction: A growing body of evidence indicates that kidney transplant recipients (KTR) with a history of pre-transplant malignancy (PTM)have a higher incidence of post-transplant de-novo…
  • 2018 American Transplant Congress

    Maintenance Immunosuppression Trends in Hand and Facial VCA Transplantation

    A. Manjunath,1 M. Cammarata,1 R. Kantar,1 W. Rifkin,1 A. Jacoby,1 B. Gelb,2 R. Diaz-Siso,1 E. Rodriguez.1

    1Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY; 2Transplant Institute, NYU Langone Health, New York, NY.

    PURPOSE: Authors have speculated that vascularized composite allotransplantation recipients (VCAR) require greater maintenance immunosuppression than solid organ recipients due to skin's higher antigenicity. This has…
  • 2018 American Transplant Congress

    Comparative Analysis of Bone Marrow versus Blood Monocyte-Derived Regulatory Dendritic Cells for Evaluation in a Miniature Swine Vascular Composite Allotransplantation Model

    T. Elgendy,1 D. Kim,2 A. Zahorchak,1 M. Ezzelarab,1 M. Solari,2 A. Thomson.1

    1Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Department of Plastic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Background: Dendritic cell therapy is a promising approach to reduced dependence on immunosuppressive drugs and for the promotion of tolerance in transplant recipients. Our aim…
  • 2018 American Transplant Congress

    Two Similar Risk Models Identify Different Patients for Graft Loss: Implications for Clinical Trials in DSA+ Kidney Transplant Recipients

    A. Bentall, B. Smith, W. Park, C. Schinstock, M. Stegall.

    William J von Liebig Transplant Center, Mayo Clinic, Rochester.

    Introduction. Kidney Transplant Recipients (KTx) with donor-specific alloantibody (DSA) at transplantation have increased death-censored graft failure (DCGF) due to chronic antibody mediated rejection (cABMR), but…
  • 2018 American Transplant Congress

    Successful Transplantation of Black Kidneys from Rhabdomyolysis Donors

    X-.P. Yuan,1 C-.B. CHen,1 Y. Zheng,1 X. Gu,2 Q. Zu,3 C. Wang,1 X. He.1

    1Organ Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; 2Department of Urology, First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China; 3Department of Urology, Chinese PLA General Hospital, Beijing, China.

    Background: The kidneys from donors with rhabdomyolysis and acute kidney injury (AKI) may show discolored appearance. The transplant surgeons may be unwilling to accept a…
  • 2018 American Transplant Congress

    DCD Kidneys with Remuzzi Scores of 4-5 Can Be Accepted for Solitary Kidney Transplantation

    X-.P. Yuan, C-.B. Chen, Y. Zheng, J. Zhou, C. Wang, X. He.

    Organ Transplant Center, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

    Background Baseline chronic donor kidney injury is usually scored using Remuzzi's classification. It has been suggested that kidneys with Remuzzi scores of 0-3 can be…
  • 2018 American Transplant Congress

    Early Steroid Withdrawal or Tacrolimus Minimization versus Standard Immunosuppression in Renal Transplant Recipients: The Allegro Trial

    J. Sanders,1 A. Gomes-Neto,1 M. v Dijk,1 M. v Sandwijk,2 H. de Fijter,3 J. Homan vd Heide,2 A. de Vries,3 F. Bemelman.2

    1Nephrology, UMCG, Groningen, Netherlands; 2Nephrology, AMC, Amsterdam, Netherlands; 3Nephrology, LUMC, Leiden, Netherlands.

    BackgroundCurrent immunosuppressive regimen in most renal transplant recipients (RTR) combines basiliximab induction with tacrolimus, mycophenolic acid and prednisolone maintenance therapy. Reduction of immunosuppression by withdrawal…
  • 2018 American Transplant Congress

    Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations in Renal Transplant Recipients

    K. Khalil, P. West-Thielke, A. Lichvar, E. Benedetti, S. Patel.

    University of Illinois Hospital & Health Sciences System, Chicago, IL.

    Purpose: To compare three formulations of tacrolimus (TAC) and assess differences in time within therapeutic range (TTR) and variability in levels.Methods: Renal transplant recipients from…
  • 2018 American Transplant Congress

    Urinary CXCL9 Monitoring to Accompany a Safe CNI-to-Belatacept Conversion in Kidney Transplant Patients

    P. Malvezzi,1 C. Fischman,2 T. Jouve,1 B. Janbon,1 P. Heeger,2 L. Rostaing,1 P. Cravedi.2

    1Service de Néphrologie, Dialyse, Aphérèses et Transplantation, CHU Grenoble Alpes, Grenoble, France; 2Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

    Background: Converting renal transplant recipients from CNI to belatacept immunosuppression has been proposed as a strategy to limit nephrotoxicity, but it is associated with an…
  • 2018 American Transplant Congress

    Living Donor Nephrectomy: Is It as Safe as It Can Be? Analysis of Living Donor Deaths in the United States

    D. Keith,1 J. Brown,2 K. Andreoni.3

    1Medicine, Sacred Heart Hospital, Pensacola, FL; 2President, Clinical Integration Solutions, LLC, Health Safety Consultancy Company, New York, NY; 3Surgery, University of Florida, Gainesville, FL.

    The reported rate of death from living donor nephrectomy is 3 in 10,000 donations. Although this risk is low, the important question is how many…
  • « Previous Page
  • 1
  • …
  • 205
  • 206
  • 207
  • 208
  • 209
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences